| 1 |
[GO] |
Neuromodec Journal |
2024―Sep―11 |
Neuromodulation for COVID-19, Neuromodec update 4: More evidence for Long-Covid and taVNS for Depressive Symptoms |
Marom Bikson |
| 2 |
[GO] |
Neuromodec Journal |
2024―Sep―11 |
Neuromodulation for COVID-19, Neuromodec update 5: Increased urgency to develop neuromodulation treatments, ongoing taVNS results |
Marom Bikson |
| 3 |
[GO] |
Neuromodec Journal |
2024―Sep―11 |
Neuromodulation for COVID-19, Neuromodec update 6: Breakthrough studies show efficacy pathways |
Marom Bikson |
| 4 |
[GO] |
Neuromodec Journal |
2024―Sep―11 |
Neuromodulation for COVID-19, Neuromodec update 7: Electronic noses, NIH “RECOVER” recruits’ patients, New prospects. |
Marom Bikson |
| 5 |
[GO] |
Neuromodec Journal |
2024―Sep―11 |
Neuromodulation for COVID-19, Neuromodec update 8: Encouraging news |
Marom Bikson |
| 6 |
[GO] |
Neuromodec Journal |
2024―Sep―11 |
Neuromodulation for COVID-19, Neuromodec update 9: More encouraging studies |
Marom Bikson |
| 7 |
[GO] |
Neuromodec Journal |
2024―Sep―11 |
Neuromodulation for COVID-19 update 3: Open trials for Long-Covid |
Marom Bikson |
